Skip to content
Stock screener

MCK McKesson Corp stock chart & analysis

Conviction 30HealthcareScan · Fri, Nov 6, 2026

McKesson Corp (MCK) closed at $1,060.84 (-1.04%) on Nov 6, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 70, RS Rating 92, -5.4% from its 52-week high, +29.3% year to date. Sector: Healthcare · Wholesale-Drugs, Proprietaries & Druggists' Sundries.

MCK$1,060.84-1.04%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
Loading chart…
McKesson CorpWholesale-Drugs, Proprietaries & Druggists' Sundrieswww.mckesson.com ↗
Price1,060.84
Change-1.04%
Gap-1.12%
Rel volume0.99×
Avg volume751.73K
Avg $ vol757.99M
SMA 201,003.16
SMA 50937.70
SMA 200867.90
Price vs 50+13.15%
Price vs 200+22.25%
MA stackbullish
50/200 cross—
Supertrendup · 1,004.96
RSI (14)70
MACD hist4.81
MACD crossbull · 2d
Stoch %K / %D64 / 77
ADX (14)29
+DI / −DI46 / 20
RSI divergence—
MACD divergence—
ATR %2.65%
ADR %2.38%
52w high1,121.50
52w low723.68
From 52w high-5.39%
Above 52w low+46.61%
New 52w highNo
SqueezeOff
Bollinger width13.23%
%B0.94
Donchian pos67.25%
Donchian high1,121.50
Donchian low936.77
AVWAP (52w high)1,078.14
vs AVWAP high-1.59%
AVWAP (52w low)844.77
vs AVWAP low+25.60%
OBV trendUp
Chaikin MF (20)0.06
Today vs 20d0.99×
Avg vol (14d)769.13K
Avg vol (20d)751.73K
Avg $ vol (20d)757.99M
Market cap122.5B
RS Rating92 / 99
RS 3m (vs SPY)+25.45%
RS 6m (vs SPY)+44.44%
RS line new highNo
Trend template6/8
Technical rank95.1
1 week+6.68%
1 month+14.06%
3 months+20.59%
6 months+44.14%
1 year+25.67%
YTD+29.35%
P/E25.72
P/B-30.98
P/S0.30
P/FCF21.42
EPS38.38
Div yield0.31%
ROE-120.44%
ROA5.16%
Debt/Eq-2.94
Current0.90
EV/EBITDA18.38
Gross margin3.61%
Net margin1.18%
Rev growth12.36%
EPS growth44.52%
Price target1,106.29
Target upside4.27%
Analyst ratingBuy
Institutional103.03%
Ent. value127.61B
Revenue110.96B
Net income1.22B
Gross profit3.96B
Free cash flow5.72B
IndustryWholesale-Drugs, Proprietaries & Druggists' Sundries
ExchangeNYSE
Shares out120.2M
Employees43K
ListedMon, Aug 3, 1987
Free float120.19M
Float %100.0%
Short interest—
Days to cover—
Short volume45.8%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est$11.68 vs $10.69
Last surprise+9.3% beat
Setup gradeD
Conviction30 / 100
Pattern quality—
Tech rank95.1 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1,023.60
Support855.70
Days since event—
Candle confirm—

Financials as of Wed, Sep 30, 2026 · quarterly.

MCK technical analysis

Trend

MCK is in an uptrend: price is above the 50-day, which is above the 200-day moving average. It closed 13.2% above the 50-day ($937.70) and 22.3% above the 200-day ($867.90). ADX(14) at 29 points to a strong, established trend. It meets 6 of 8 trend-template criteria.

Momentum

RSI(14) is 70, in overbought territory. MACD crossed above its signal line 2 sessions ago. Its RS Rating of 92 puts its weighted 12-month performance ahead of about 92% of the US market.

Volume and volatility

Volume on the latest session ran 1.0× its 20-day average. It trades about $758.0M a day on average. ATR(14) is $28.07, 2.6% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (0.06) shows accumulation.

Key levels

The chart pattern's support is $855.70 and its resistance $1,023.60. The 52-week range is $723.68 to $1,121.50; price is 5.4% below the high and 46.6% above the low. The VWAP anchored at the 52-week high is $1,078.14, above price.

Performance

MCK returned +6.7% (1 week), +14.1% (1 month), +20.6% (3 months), +44.1% (6 months), +25.7% (1 year), +29.3% (year to date).

About McKesson Corp

McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Wholesale-Drugs, Proprietaries & Druggists' Sundries · Listed 1987 · 43,000 employees

Congress activity

Disclosed STOCK Act trades in MCK · 10 recent

All disclosures →
MemberSideAmount
Alan Armstrong
Alan Armstrong
senate · R · OK · traded 2026-03-27
Buy$1K–$15K
Jonathan Jackson
Jonathan Jackson
house · D · IL · traded 2026-06-15
Sell$1K–$15K
Rick Larsen
Rick Larsen
house · D · WA · traded 2026-07-08
Buy$1K–$15K
Ritchie John Torres
Ritchie John Torres
house · D · NY · traded 2025-01-07
Buy$1K–$15K
Elizabeth Fletcher
Elizabeth Fletcher
house · TX · traded 2026-04-08
Sell$1K–$15K
Markwayne Mullin
Markwayne Mullin
senate · traded 2026-02-04
Buy$15K–$50K
Markwayne Mullin
Markwayne Mullin
senate · traded 2026-01-05
Buy$15K–$50K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2025-12-19
Sell$1K–$15K
Jared Moskowitz
Jared Moskowitz
house · FL · traded 2025-12-02
Buy$1K–$15K
Jared Moskowitz
Jared Moskowitz
house · D · FL · traded 2025-10-10
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in MCK · open-market 6 sells

InsiderSideShares
Fraga Francisco
EVP, CIO and CTO · Common Stock · 2026-11-05
Sell650
Fraga Francisco
EVP, CIO and CTO · Common Stock · 2026-11-04
Sell600
Fraga Francisco
EVP, CIO and CTO · Common Stock · 2026-11-03
Exercise398
Fraga Francisco
EVP, CIO and CTO · Restricted Stock Units (RSUs) · 2026-11-03
Disposition398
Fraga Francisco
EVP, CIO and CTO · Common Stock · 2026-11-03
Tax157
Fraga Francisco
EVP, CIO and CTO · Common Stock · 2026-10-15
Sell800.491
Lerman Bradley E
Director · Common Stock · 2026-08-10
Sell301
Srinivasan Ramesh (NMN)
EVP and Chief Strategy Officer · Restricted Stock Units (RSUs) · 2026-08-07
Grant368
TYLER BRIAN S.
Chief Executive Officer · Common Stock · 2026-07-07
Sell8.46K
TYLER BRIAN S.
Chief Executive Officer · Common Stock · 2026-06-17
Sell8.46K

SEC filings

EDGAR filings in MCK · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.